PRDX1 is also associated with tumor invasiveness, metastasis, and chemotherapy resistance in gastric cancer (GC) and other cancers such as pancreatic cancer (PC), ovarian cancer (OC), and prostate cancer (PCa), emphasising its essential biological function across various malignancies (Lai et al., 2024). This evidence concerns the gene PRDX1 and familial pancreatic carcinoma.